Group News Home > News Info > Group News
Penetrating Micelle for Reversing Immunosuppression and Drug Resistance in Pancr...
Time:2022/5/5 20:10:29
Recently, our group has developed a nanodrug delivery system based on charge reversal strategy to overcome the dense matrix of pancreatic cancer and re-educate the tumor immunosuppressive microenvironment.The relevant papers were published in the internation...
+More
Recent advances in targeted drug delivery for the treatment of pancreatic ductal...
Time:2022/3/12 15:23:21
Recently, our group was invited to publish a review article on the design of targeted delivery systems for pancreatic cancer. The article was published online in the journal Expert opinion on drug delivery with the title Recent advances in targeted drug deliv...
Nanodrug delivery systems for ferroptosis-based cancer therapy
Time:2022/1/31 12:20:03
Recently, our group published a review article on the design of ferroptosis-based cancer therapeutic delivery systems. The article was published online in the Journal of controlled release with the title "Nanodrug delivery systems for ferroptosis-based cance...
A Micro-Environment Regulator for Filling the Clinical Treatment Gap after a Gli...
Time:2022/1/20 14:51:29
Glioblastoma (GBM) is the most invasive and malignant intracranial tumor in the central nervous system. Although the combination of surgery and adjuvant radiotherapy and chemotherapy is actively used in the clinical treatment of GBM, the median survival time...
Exosomes derived from immunogenically dying tumor cells as a versatile tool for ...
Time:2022/1/10 17:01:21
Recently, our research group developed ananovaccineusing exosomes derived from immunogenically dying tumor cells to modulate the immunosuppressive microenvironment of pancreatic ductal adenocarcinoma (PDAC) and enhance immunotherapy. The relevant studies we...
Room 713, Scientific research building, School of pharmacy, Fudan university, No. 826, Zhangheng Road, Pudong new area, Shanghai Zip:201203 Tel 021-50772670 Copy Right @ 2024 Jiang Group. All rights reserved.
X